Latest Breaking News On - Ministry of national guard health affairs - Page 1 : comparemela.com

In Saudi Arabia, machine learning model helps reduce outpatient no-shows

Using AI-enabled analytics has allowed Ministry of National Guard Health Affairs in Riyadh, already an accomplished HIMSS adopter, to make big improvements to a fundamental challenge.

Saudi arabiaKingdom of saudi arabiaHuda al ghamdiAl ghamdiMinistry of national guard health affairsNational guard health affair riyadh basedKing abdulaziz medical cityNational guard health affairs

Vertex Pharmaceuticals Incorporated: Vertex Announces Approval of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY, for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT) in Kingdom of Saudi Arabia

Vertex Pharmaceuticals Incorporated: Vertex Announces Approval of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY, for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT) in Kingdom of Saudi Arabia
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomSaudi arabiaKingdom of saudi arabiaHeather nicholsReshma kewalramaniManisha paiCompanies to workTreatment centerVertex pharmaceuticals incorporated nasdaqExchange commissionDrug authorityVertex pharmaceuticals incorporatedBreakthrough medicines programMinistry of national guard health affairs

Vertex Pharma (VRTX) Announces Approval of CASGEVY in Saudi Arabia

Vertex Pharma (VRTX) Announces Approval of CASGEVY in Saudi Arabia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomSaudi arabiaKingdom of saudi arabiaHeather nicholsReshma kewalramaniManisha paiMinistry of national guard health affairsExchange commissionCompanies to workVertex pharmaceuticals incorporated nasdaqTreatment centerVertex pharmaceuticals incorporatedDrug authoritySaudi food

Vertex Announces Approval of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™, for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT) in Kingdom of Saudi Arabia

- CASGEVY™ is first medicine ever to be evaluated through the SFDA’s Breakthrough Medicines Program - - First treatment center in Saudi Arabia has been activated - .

United statesCity ofUnited kingdomSaudi arabiaKingdom of saudi arabiaReshma kewalramaniDrug authorityCompanies to workTreatment centerVertex pharmaceuticals incorporated nasdaqMinistry of national guard health affairsExchange commissionVertex pharmaceuticals incorporatedSaudi foodMarketing authorizationChief executive officer

KSA ID Week to tackle global health challenges

KSA ID Week to tackle global health challenges
arabnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from arabnews.com Daily Mail and Mail on Sunday newspapers.

Saudi arabiaAr riyaMajid al shamraniMohammed al zunitanFayssal farahatMinistry of national guard health affairsKing abdulaziz medical cityNational guard health affairs